
Retatrutide
triple-agonist incretin reference compound
FOR LABORATORY RESEARCH ONLY · NOT FOR HUMAN OR VETERINARY USE · NOT A DRUG, SUPPLEMENT, OR THERAPEUTIC
HPLC + MS VERIFIEDUSA SYNTHESIZED
Lyophilized peptide reference standards manufactured in the United States, sealed in amber glass, and verified by an independent third-party laboratory before release. Every lot is HPLC + MS quantified and ships with a downloadable certificate of analysis.


triple-agonist incretin reference compound

pentadecapeptide reference compound

synthetic 44-AA fragment reference (Thymosin β4)

copper tripeptide-1 complex
Each batch is synthesized in our audited US facility, lyophilized under vacuum, and submitted to an independent third-party laboratory for HPLC and MS quantification before any unit enters the shipping queue.
Solid-phase peptide synthesis under cleanroom protocol. Each crude product is logged against a unique lot identifier — IL-YYWW-xxxN.
Dried under vacuum, sealed in amber glass under inert gas. Vials are stable at -20°C and labeled with lot, mass, and synthesis date.
A representative sample from every lot is HPLC purity-quantified and MS molecular-weight-confirmed by a contract analytical lab.
A signed certificate is bound to the lot identifier and made available for download from the verification archive before shipping begins.